Asset
MP-0250
Molecular Partners AG American Depositary Shares
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT02194426 | phase1_2 | completed | 2014-07-01 | 2018-02-20 | Molecular Partners AG | First-in-human Study to Investigate the Safety, Tolerability and Blood Levels of the Test Drug MP0250 in Cancer Patients |
FDA applications (0)
This company has no applications containing this asset.